Published in Science on September 12, 1986
The role of liver biopsy in chronic hepatitis C. Hepatology (2001) 2.47
Reduction of intrapulmonary shunt and resolution of digital clubbing associated with primary biliary cirrhosis after liver transplantation. Hepatology (1990) 2.06
The utility of the 13C-galactose breath test as a measure of liver function. Aliment Pharmacol Ther (2003) 1.43
Ultrasound-guided liver biopsy for parenchymal liver disease: an economic analysis. Dig Dis Sci (1998) 1.41
The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol (1999) 1.40
Chemical peeling as adjuvant therapy for facial neurotic excoriations. J Am Acad Dermatol (1994) 1.37
When is endoscopic polypectomy adequate therapy for colonic polyps containing invasive carcinoma? Gastroenterology (1986) 1.23
Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology (1995) 1.20
Cryptosporidial enteritis in a homosexual male with an acquired immunodeficiency syndrome. Cleve Clin Q (1983) 1.08
Neurological complications following liver transplantation. Ann Neurol (1992) 1.01
The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology (1997) 0.97
Neurologic complications of liver transplantation. Transplantation (1988) 0.97
Prevalence and reversibility of the hepatopulmonary syndrome after liver transplantation. The Cleveland Clinic experience. West J Med (1995) 0.96
Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis. Ann Hepatol (2013) 0.96
Sarcoidosis of the eyelid skin. Can J Ophthalmol (1990) 0.94
Hepatitis C infection risk analysis: who should be screened? Comparison of multiple screening strategies based on the National Hepatitis Surveillance Program. Am J Gastroenterol (1998) 0.93
Clinical features and follow-up of surreptitious laxative users. Cleve Clin Q (1984) 0.91
Peer review revisited. Science (1975) 0.91
Immunogenicity of hepatitis A vaccine in decompensated liver disease. Am J Gastroenterol (1999) 0.89
A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy. J Hepatol (2001) 0.84
Recurrent acute pancreatitis and intussusception complicating an intraluminal duodenal diverticulum. Gastroenterology (1981) 0.84
Risk of extraesophageal malignancy in patients with adenocarcinoma arising in Barrett's esophagus. Am J Gastroenterol (1995) 0.84
Prevalence of colonic neoplasia in patients with Barrett's esophagus. Am J Gastroenterol (1993) 0.83
Pulmonary lymphangiomyomatosis. Chest (1984) 0.83
Endoscopic small bowel mucosal biopsy: a controlled trial evaluating forceps size and biopsy location in the diagnosis of normal and abnormal mucosal architecture. Gastrointest Endosc (1989) 0.82
Drug and treatment efficacy of chenodeoxycholic acid in 97 patients with cholelithiasis and increased surgical risk. Dig Dis Sci (1983) 0.82
Clindamycin colitis--an emerging problem. West J Med (1974) 0.82
Annual report of the executive officer. Science (1987) 0.81
The shaming of science. Science (1975) 0.81
Concomitant hepatitis B surface antigen and antibody in thirteen patients. Ann Intern Med (1983) 0.81
Spontaneous bacterial peritonitis: clinical and laboratory features with reference to hospital-acquired cases. Am J Gastroenterol (1986) 0.80
A multivariate analysis of risk factors for cytomegalovirus infection in liver-transplant recipients. Gastroenterology (1990) 0.79
Removal of protein-bound toxins from critical care patients. Clin Toxicol (1980) 0.79
Comparison of suction capsule and endoscopic biopsy of small bowel mucosa. Gastrointest Endosc (1986) 0.78
Topical mupirocin versus topical neosporin in the treatment of cutaneous infections. Int J Dermatol (1988) 0.78
Medical therapy for gallstones. 1. Rationale and indications. Postgrad Med (1982) 0.78
Klippel-Trenaunay-Weber syndrome with visceral involvement and portal hypertension. Cleve Clin Q (1982) 0.77
Selective bowel decontamination with quinolones and nystatin reduces gram-negative and fungal infections in orthotopic liver transplant recipients. Cleve Clin J Med (1993) 0.76
Screening for colorectal cancer. N Engl J Med (1993) 0.75
Colon polyps and cancer in 1994. Am J Gastroenterol (1994) 0.75
The United States and the IIASA Connection. Science (1986) 0.75
Medical therapy for gallstones. 2. Initiation and monitoring. Postgrad Med (1982) 0.75
Science education: rhetoric and reality. Science (1981) 0.75
1984: Science's Multicolored Coat. Science (1983) 0.75
Hypertensive lower esophageal sphincter. Dig Dis Sci (1989) 0.75
Science finds its voice. Science (1984) 0.75
1979 report of the executive officer. Science (1980) 0.75
Nonhomogeneous copper distribution in primary biliary cirrhosis. Cleve Clin Q (1980) 0.75
Science and the national security. Science (1981) 0.75
Hypernephroma with metastasis to the duodenum: endoscopic features. Gastrointest Endosc (1980) 0.75
Science and the Philadelphia story. Science (1985) 0.75
Science: its place in AAAS. Science (1980) 0.75
Interferon for chronic hepatitis. Cleve Clin J Med (1990) 0.75
1978 report of the executive officer. Science (1979) 0.75
Failure of LeVeen shunting in refractory ascites--a view from the other side. Surgery (1981) 0.75
Charting a course for science. Science (1981) 0.75
Science policy in washington. Science (1979) 0.75
A run worth making. Science (1983) 0.75
Evaluating treatment options for chronic liver disease. Cleve Clin J Med (1989) 0.75
Drift and danger in u.s.-Soviet relations. Science (1980) 0.75
Pruritus of cholestasis treated with plasma perfusion. Am J Gastroenterol (1981) 0.75
Defense r&d priorities. Science (1984) 0.75
Science and public understanding. Science (1979) 0.75
Stalking Innovation's Woes. Science (1979) 0.75
Annual report of the executive officer. Science (1986) 0.75
1980 report of the executive officer. Science (1981) 0.75
Equity and economics. Science (1981) 0.75
1983 annual report of the executive officer. Science (1984) 0.75
How in the world are we? Science (1986) 0.75
Science policy: new directions? Science (1980) 0.75
Arms control and intricacy. Science (1985) 0.75
Hashimoto's thyroiditis, primary biliary cirrhosis, and myasthenia gravis. Am J Clin Pathol (1980) 0.75
1982 annual report of the executive officer. Science (1983) 0.75
Annual report of the executive officer. Science (1985) 0.75
The fifth decade. Science (1986) 0.75
A transition for science. Science (1983) 0.75
More on ascitic fluid analysis. Hepatology (1985) 0.75
Survival politics: science and the budget dilemma. Science (1986) 0.75
The evolving serology of viral hepatitis. Prim Care (1981) 0.75
A welcome grace note. Science (1985) 0.75
Censorship, soviet style. Science (1983) 0.75
Coping with gridlock. Science (1983) 0.75
On institutional memory. Science (1986) 0.75
An improved method for the establishment of cell lines from primary skin melanomas. Br J Dermatol (1984) 0.75
Roles of the Bureau of the Budget. Science (1967) 0.75
Handcuffing science. Science (1982) 0.75
Affordable science. Science (1981) 0.75
Dilemmas of scale. Science (1982) 0.75
The threshold of pain: coping with frugality. Science (1981) 0.75
Science in an election year. Science (1982) 0.75
Ascitic fluid removal: does it cause renal or hemodynamic decompensation? Cleve Clin Q (1983) 0.75
Science and the politics of development. Science (1979) 0.75
The eagle and the bear. Science (1980) 0.75
Science: matters of scale and purpose. Science (1985) 0.75
Science policy and congress. Science (1981) 0.75
The elegance of choosing. Science (1984) 0.75
Guidelines for training in gallstone lithotripsy. Ann Intern Med (1991) 0.75
1981 annual report of the executive officer. Science (1982) 0.75
Clinical hepatic support by on-line plasma treatment with multiple sorbents - evaluation of system performance. Trans Am Soc Artif Intern Organs (1980) 0.75